Biopharmaceuticals Inc. , an affiliate of Ipsen (Euronext:IPN;
ADR:IPSEY) today announced three presentations of lanreotide data
to be shared at the 2015 Gastrointestinal Cancers Symposium, January
15-17, 2015 in San Francisco, CA.
for Ipsen Biopharmaceuticals to Present Further Data on Recently FDA-Approved Antitumor Therapy, Somatuline® Depot® (lanreotide), at Gastrointestinal Cancers Symposium investment picks